Life Biosciences, Leading Developer Of Therapeutics For Aging-Related Diseases, Completes $82 Million Series C Financing Round
Amount Raised
$82 Million
Round Type
Series C
Description
Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced the completion of a Series C financing of $82 million led by Alpha Wave Ventures. Senior management and founders invested in the Series C financing alongside longevity-oriented funds, seasoned investors, and experienced biotechnology scientists/entrepreneurs. Since its founding, Life Biosciences has raised over $158 million.
Quick answer
Life Biosciences raised $82 Million in a Series C round, dated January 5, 2022. Life Biosciences is based in Boston, Massachusetts, United States.
- How much did Life Biosciences raise?
- Life Biosciences raised $82 Million in a Series C round on January 5, 2022.
- What does Life Biosciences do?
- Life Bio is a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging.
- Where is Life Biosciences based and how big is it?
- Life Biosciences is based in Boston, Massachusetts, United States. Fundz records about 24 employees.
- Who are the decision-makers at Life Biosciences?
- Fundz holds 2 contacts at Life Biosciences, including the Associate Director, Molecular Biology & Gene Delivery. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Life Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Confluent Medical raised an undisclosed amount on February 17, 2022.
- Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
- Neo Medical raised $21M (Funding Round) on February 17, 2022.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Memo Therapeutics AG raised an undisclosed amount (Series B) on February 16, 2022.
- Electra Therapeutics raised $84M (Series B) on February 16, 2022.
Who to call at Life Biosciences, and when
A new round usually means Life Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Life Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Life Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Life Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Life Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Life Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.